Olema Pharmaceuticals (OLMA) Payables (2020 - 2026)

Olema Pharmaceuticals (OLMA) has 7 years of Payables data on file, last reported at $3.7 million in Q1 2026.

• On a quarterly basis, Payables rose 2362.91% year-over-year to $3.7 million in Q1 2026; TTM through Mar 2026 was $3.7 million, a 2362.91% increase from a year earlier, with the FY2025 full-year figure at $9.3 million, up 107.47% from the prior year.
• Payables for Q1 2026 stood at $3.7 million, down from $9.3 million in the prior quarter.
• Over the last five years, Payables for OLMA reached as high as $9.3 million in Q4 2025 and fell as low as $14000.0 in Q3 2022.
• Historically, Payables has averaged $2.6 million across 5 years, with a median of $2.2 million in 2023.
• Across the five-year window, Payables jumped 15664.29% in 2023 and sank 98.03% in 2025, its largest moves.
• Year by year, Payables stood at $374000.0 in 2022, then jumped by 621.39% to $2.7 million in 2023, then jumped by 65.31% to $4.5 million in 2024, then soared by 107.47% to $9.3 million in 2025, then plunged by 59.81% to $3.7 million in 2026.
• Per Business Quant data, the three most recent Payables figures were $3.7 million in Q1 2026, $9.3 million in Q4 2025, and $3.5 million in Q3 2025.